Interestingly, as determined in breast cancer datasets (Fig. 1h), enhanced TGF-β signaling activity was also positively correlated with increased sEV secretion in vitro as quantified by total sEV protein through BCA assay (Fig. 2b and Supplementary Fig. 3a). Here, TGFB1 is linked to breast cancer.